Hongzhao Qi
- Cancer Research top 2%
- MicroRNA in disease regulation 14
- Cancer-related molecular mechanisms research 5
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 14
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 14
- Extracellular vesicles in disease 14
- Circular RNAs in diseases 7
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 8
- Bone Tissue Engineering Materials 5
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hongzhao Qi
51 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 745
- Biomaterials 324
- Molecular Biology 1.5k
- Business and International Management 34
- Biomedical Engineering 467
Countries citing papers authored by Hongzhao Qi
This map shows the geographic impact of Hongzhao Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzhao Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzhao Qi more than expected).
Fields of papers citing papers by Hongzhao Qi
This network shows the impact of papers produced by Hongzhao Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzhao Qi. The network helps show where Hongzhao Qi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongzhao Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 9 | |
| 7 | 2022 | 68 | |
| 8 | 2022 | 40 | |
| 9 | 2022 | 41 | |
| 10 | 2022 | 19 | |
| 11 | 2021 | 41 | |
| 12 | 2020 | 38 | |
| 13 | 2020 | 45 | |
| 14 | 2020 | 17 | |
| 15 | 2020 | 15 | |
| 16 | 2019 | 25 | |
| 17 | 2019 | 32 | |
| 18 | 2019 | 110 | |
| 19 | 2018 | 10 | |
| 20 | 2018 | 52 |
About Hongzhao Qi
Hongzhao Qi is a scholar working on Cancer Research, Biomaterials and Business and International Management, having authored 52 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), MicroRNA in disease regulation (14 papers), Nanoparticle-Based Drug Delivery (14 papers), Extracellular vesicles in disease (14 papers), Nanoplatforms for cancer theranostics (8 papers), Circular RNAs in diseases (7 papers), Cancer-related molecular mechanisms research (5 papers) and Bone Tissue Engineering Materials (5 papers). The work is most often cited by research in Cancer Research (745 citations), Biomaterials (324 citations) and Molecular Biology (1.5k citations). Hongzhao Qi has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xubo Yuan, Peifeng Li, Jin Zhao, Xin Hou, Chunsheng Kang, Chaoyong Liu, Tao Yu, Yanyan Yang, Xiuxiu Fu and Tianxiang Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.